๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Accelerated fractionation in inoperable non-small cell lung cancer. A phase I/II study

โœ Scribed by Edward Yu; Luis Souhami; Julio Guerra; Brenda Clark; Carole Gingras; Palma Fava


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
439 KB
Volume
71
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase II trial of edatrexate in small ce
โœ Martin Wiesenfeld; James R. Jett; John Q. Su; Theodore A. Braich; Carl G. Kardin ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 435 KB ๐Ÿ‘ 2 views
Vinorelbine in elderly patients with ino
โœ Gianfranco Buccheri; Domenico Ferrigno ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 2 views

## BACKGROUND. Cancer in the elderly is becoming a complex and frequent issue. At least 30% of lung carcinomas are expected to arise each year in elderly patients, who often have significant comorbidity. The most appropriate treatment for this large portion of cancer patients remains unknown. The

A cross-sectional study of vitamin intak
โœ Jatoi, Aminah; Daly, Benedict D.T.; Kramer, Gertrude; Mason, Joel B. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 2 views

## Background and objectives: This cross-sectional study of postoperative non-small cell lung cancer (nsclc) patients examined possible effects of vitamin intake and folate status on disease-free survival. ## Methods: Supplemental vitamin usage, dietary vitamin intake (willett food frequency ques

Carboplatin, etoposide, and accelerated
โœ Branislav Jeremic; Yuta Shibamoto; Ljubisa Acimovic; Slobodan Milisavljevic ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 173 KB ๐Ÿ‘ 2 views

## Background: It is not clear how well elderly patients with limited small cell lung carcinoma tolerate intensive chemotherapy, and they have often been treated with palliative intent. as an alternative strategy, the authors designed and employed a short term combination regimen consisting of carb

A phase II trial of oral tegafur and ura
โœ Yukito Ichinose; Nobuko Takanashi; Tokujiro Yano; Hiroshi Asoh; Hideki Yokoyama; ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 391 KB ๐Ÿ‘ 2 views

## Background: The combination of uracil and tegafur in a 4:1 molar concentration (uft) has a greater antitumor activity than 5-fluorouracil (5-fu) and tegafur. because the combination of 5-fu and cisplatin has been proven to have a synergistic antitumor effect in many experimental and clinical stu